To sum up, our results provide first evidence that CTHRC1 interacts with integrin β3 and accelerates the FAK phosphorylation to promote ovarian cancer cell adhesion, migration and invasion in vitro and in vivo. Here, PTK2 is linked to ovarian cancer.